DecisionPoint Financial’s Bristol-Myers Squibb BMY Stock Holding History

DecisionPoint Financial’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$304	Sell	5 -100	-95%	-$5.83K	﹤0.01%	566
2025 Q4	$5.66K	Buy	105 +100	+2,000%	+$4.81K	﹤0.01%	238
2025 Q3	$238	Hold	5	–	–	﹤0.01%	602
2025 Q2	$238	Sell	5 -500	-99%	-$24.5K	﹤0.01%	586
2025 Q1	$30.8K	Hold	505	–	–	0.01%	104
2024 Q4	$28.6K	Hold	505	–	–	0.01%	104
2024 Q3	$26.1K	Hold	505	–	–	0.01%	110
2024 Q2	$24K	Hold	505	–	–	0.01%	116
2024 Q1	$22.6K	Sell	505 -652	-56%	-$33.2K	0.01%	115
2023 Q4	$59.4K	Hold	1,157	–	–	0.03%	66
2023 Q3	$67.2K	Sell	1,157 -348	-23%	-$21.3K	0.04%	52
2023 Q2	$96.2K	Hold	1,505	–	–	0.05%	40
2023 Q1	$104K	Hold	1,505	–	–	0.06%	36
2022 Q4	$108K	Buy	+1,505	New	+$113K	0.07%	33

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DecisionPoint Financial's BMY Position: Q1 2026 in Review

DecisionPoint Financial reduced its Bristol-Myers Squibb (BMY) stake by 95% in Q1 2026, selling an estimated $5.83K and leaving 5 shares worth $304. The position accounts for ﹤0.01% of the portfolio, ranked #566.

DecisionPoint Financial first reported a position in BMY in Q4 2022 and has held it in 14 quarters since. The position peaked at $108K in Q4 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

DecisionPoint Financial held 5 shares of Bristol-Myers Squibb worth $304 as of Q1 2026.
DecisionPoint Financial sold 100 Bristol-Myers Squibb shares in Q1 2026, an estimated $5.83K.
Bristol-Myers Squibb made up ﹤0.01% of DecisionPoint Financial's portfolio in Q1 2026, its #566 holding.
DecisionPoint Financial first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 14 quarters since.
DecisionPoint Financial's Bristol-Myers Squibb position peaked at $108K in Q4 2022.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on DecisionPoint Financial's 13F filing for Q1 2026, filed 6 May 2026.